Low dose aspirin/esomeprazole magnesium combination product regulatory update

AstraZeneca submitted an NDA to FDA for its low dose aspirin/esomeprazole magnesium combination product to reduce the risk of low dose aspirin-associated gastric and/or duodenal ulcers. The company's ...